{"id":{"repo_id":"uiuc","oai_identifier":"oai:www.ideals.illinois.edu:2142/108214"},"canonical_url":"https://search.dev.ndltd.org/etd/uiuc/oai:www.ideals.illinois.edu:2142/108214","repository":{"repo_id":"uiuc","name":"University of Illinois - Urbana-Champaign","base_url":"https://www.ideals.illinois.edu/oai-pmh"},"display":{"title":"Diverse functions of LanC-like proteins in mammalian cells","abstract":"Bacterial LanC proteins have been extensively studied and shown to be responsible for installing thioether crosslinks in precursors of lanthipeptides. These modifications allow lanthipeptides to possess different biological activities such as antimicrobial activity. LanC-like proteins have been identified in various eukaryotic cells, but their function is not known. Intriguingly, the structure of the bi-functional enzyme CylM was solved and the dehydratase domain of LanM unexpectedly showed structural homology with mammalian kinases such as the mammalian target of rapamycin (mTOR). This finding has led us to look for potential interaction partners for LanCL proteins. In Chapter 2, I demonstrate that LanCL proteins physically interact with many cellular kinases in mammalian cells by using pulldown assays. Since LanCL proteins have been shown to bind glutathione (GSH), I hypothesized that LanCL proteins might act as post-translational modification enzymes to modify proteins/peptides. In this study, dehydroamino acids containing peptides that mimic the activation loop of Erk and Akt protein kinases were synthesized. LanCL proteins were shown to add GSH to these dehydroamino acids containing peptides. The same C-glutathionylation was also observed by using dehydroamino acid containing proteins as substrates. These data show that LanCL proteins have flexible capabilities to catalyze C-glutathionylation on different substrates. GC-MS analysis showed that the C-glutathionylation catalyzed by LanCL2 involves formation of DL-(methyl)lanthionine linkages. In order to probe the biological function of C-glutathionylation in mammalian cells, affinity purification mass spectrometry-based (AP-MS) proteomic analysis was performed which is presented in Chapter 3. Based on the bioinformatic analysis of the proteomic data, it seems LanCL2 participates in different metabolic pathways as well as protein degradation pathways. I therefore hypothesized that C-glutathionylation might act as a beacon for protein degradation; however, my preliminary data do not support a model that C-glutathionylation is a tag for protein degradation in mammalian cells. Instead, LanCL proteins may function to remove detrimental electrophilic sites from the proteome. In addition to acting as an enzyme in mammalian cells, we showed that LanCL2 might also act as a positive regulator for PPAR activity in Chapter 4. LanCL2 knockdown (KD) in preadipocytes led to disruption of their differentiation capability and pulldown assays showed that LanCL2 physically interacts with PPAR in HEK293 and 3T3-L1 cells. An in vitro binding study further showed that LanCL2 directly interacts with PPAR. Finally, luciferase reporter assays showed that LanCL2 is important for PPAR transactivation activity. Taken together, my thesis research suggests different roles of LanCL proteins in mammalian cells.","abstract_html":"Bacterial LanC proteins have been extensively studied and shown to be responsible for installing thioether crosslinks in precursors of lanthipeptides. These modifications allow lanthipeptides to possess different biological activities such as antimicrobial activity. LanC-like proteins have been identified in various eukaryotic cells, but their function is not known. Intriguingly, the structure of the bi-functional enzyme CylM was solved and the dehydratase domain of LanM unexpectedly showed structural homology with mammalian kinases such as the mammalian target of rapamycin (mTOR). This finding has led us to look for potential interaction partners for LanCL proteins. In Chapter 2, I demonstrate that LanCL proteins physically interact with many cellular kinases in mammalian cells by using pulldown assays. Since LanCL proteins have been shown to bind glutathione (GSH), I hypothesized that LanCL proteins might act as post-translational modification enzymes to modify proteins/peptides. In this study, dehydroamino acids containing peptides that mimic the activation loop of Erk and Akt protein kinases were synthesized. LanCL proteins were shown to add GSH to these dehydroamino acids containing peptides. The same C-glutathionylation was also observed by using dehydroamino acid containing proteins as substrates. These data show that LanCL proteins have flexible capabilities to catalyze C-glutathionylation on different substrates. GC-MS analysis showed that the C-glutathionylation catalyzed by LanCL2 involves formation of DL-(methyl)lanthionine linkages. In order to probe the biological function of C-glutathionylation in mammalian cells, affinity purification mass spectrometry-based (AP-MS) proteomic analysis was performed which is presented in Chapter 3. Based on the bioinformatic analysis of the proteomic data, it seems LanCL2 participates in different metabolic pathways as well as protein degradation pathways. I therefore hypothesized that C-glutathionylation might act as a beacon for protein degradation; however, my preliminary data do not support a model that C-glutathionylation is a tag for protein degradation in mammalian cells. Instead, LanCL proteins may function to remove detrimental electrophilic sites from the proteome. In addition to acting as an enzyme in mammalian cells, we showed that LanCL2 might also act as a positive regulator for PPAR activity in Chapter 4. LanCL2 knockdown (KD) in preadipocytes led to disruption of their differentiation capability and pulldown assays showed that LanCL2 physically interacts with PPAR in HEK293 and 3T3-L1 cells. An in vitro binding study further showed that LanCL2 directly interacts with PPAR. Finally, luciferase reporter assays showed that LanCL2 is important for PPAR transactivation activity. Taken together, my thesis research suggests different roles of LanCL proteins in mammalian cells.","abstract_has_math":false,"creators":["Lai, Kuan-Yu Nick"],"institution":"University of Illinois at Urbana-Champaign","degree_name":"Ph.D.","degree_level":"Dissertation","degree_discipline":"Biochemistry","degree_department":null,"school":null,"contributors":["van der Donk, Wilfred A.","Nair, Satish K.","Procko, Erik","Chen, Jie"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2020,"date_issued":"2020-08-27T00:46:46Z","date_published":"2020-08-27T00:46:46Z","updated_at":"2026-07-22T22:24:48Z","subjects":["LanCL, Enzyme, Glutathionylation"],"languages":["en"],"rights":["Copyright 2019 Kuan-Yu Nick Lai"],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/2142/108214","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["van der Donk, Wilfred A.","Nair, Satish K.","Procko, Erik","Chen, Jie"]},{"key":"dc:creator","label":"Author","values":["Lai, Kuan-Yu Nick"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2020-08-27T00:46:46Z","2022-08-27T00:51:40Z","2020-01-15","2020-05"]},{"key":"dc:type","label":"Dc Type","values":["text","Thesis"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biochemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Illinois at Urbana-Champaign"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["LanCL, Enzyme, Glutathionylation"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["Copyright 2019 Kuan-Yu Nick Lai"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["http://hdl.handle.net/2142/108214"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Bacterial LanC proteins have been extensively studied and shown to be responsible for installing thioether crosslinks in precursors of lanthipeptides. These modifications allow lanthipeptides to possess different biological activities such as antimicrobial activity. LanC-like proteins have been identified in various eukaryotic cells, but their function is not known. Intriguingly, the structure of the bi-functional enzyme CylM was solved and the dehydratase domain of LanM unexpectedly showed structural homology with mammalian kinases such as the mammalian target of rapamycin (mTOR). This finding has led us to look for potential interaction partners for LanCL proteins. In Chapter 2, I demonstrate that LanCL proteins physically interact with many cellular kinases in mammalian cells by using pulldown assays. Since LanCL proteins have been shown to bind glutathione (GSH), I hypothesized that LanCL proteins might act as post-translational modification enzymes to modify proteins/peptides. In this study, dehydroamino acids containing peptides that mimic the activation loop of Erk and Akt protein kinases were synthesized. LanCL proteins were shown to add GSH to these dehydroamino acids containing peptides. The same C-glutathionylation was also observed by using dehydroamino acid containing proteins as substrates. These data show that LanCL proteins have flexible capabilities to catalyze C-glutathionylation on different substrates. GC-MS analysis showed that the C-glutathionylation catalyzed by LanCL2 involves formation of DL-(methyl)lanthionine linkages. In order to probe the biological function of C-glutathionylation in mammalian cells, affinity purification mass spectrometry-based (AP-MS) proteomic analysis was performed which is presented in Chapter 3. Based on the bioinformatic analysis of the proteomic data, it seems LanCL2 participates in different metabolic pathways as well as protein degradation pathways. I therefore hypothesized that C-glutathionylation might act as a beacon for protein degradation; however, my preliminary data do not support a model that C-glutathionylation is a tag for protein degradation in mammalian cells. Instead, LanCL proteins may function to remove detrimental electrophilic sites from the proteome. In addition to acting as an enzyme in mammalian cells, we showed that LanCL2 might also act as a positive regulator for PPAR activity in Chapter 4. LanCL2 knockdown (KD) in preadipocytes led to disruption of their differentiation capability and pulldown assays showed that LanCL2 physically interacts with PPAR in HEK293 and 3T3-L1 cells. An in vitro binding study further showed that LanCL2 directly interacts with PPAR. Finally, luciferase reporter assays showed that LanCL2 is important for PPAR transactivation activity. Taken together, my thesis research suggests different roles of LanCL proteins in mammalian cells.","Submission published under a 24 month embargo labeled 'Closed Access', the embargo will last until 2022-05-01","The student, Kuan-Yu Lai, accepted the attached license on 2020-01-02 at 03:13.","The student, Kuan-Yu Lai, submitted this Dissertation for approval on 2020-01-02 at 03:20.","This Dissertation was approved for publication on 2020-01-15 at 09:10.","DSpace SAF Submission Ingestion Package generated from Vireo submission #14839 on 2020-08-25 at 17:38:16","Made available in DSpace on 2020-08-27T00:46:46Z (GMT). No. of bitstreams: 2 LAI-DISSERTATION-2020.pdf: 30449286 bytes, checksum: ad434a858aa9373a2ffc519987ba26b2 (MD5) LICENSE.txt: 4208 bytes, checksum: 9430999de29cd23c31dab22eac972954 (MD5) Previous issue date: 2020-01-15","Embargo set by: Seth Robbins for item 115827 Lift date: 2022-08-27T00:46:59Z Reason: Author requested closed access (OA after 2yrs) in Vireo ETD system","Embargo set by: Seth Robbins for item 115827 Lift date: 2022-08-27T00:50:22Z Reason: Author requested closed access (OA after 2yrs) in Vireo ETD system","Embargo set by: Seth Robbins for item 115827 Lift date: 2022-08-27T00:51:40Z Reason: Author requested closed access (OA after 2yrs) in Vireo ETD system","Author requested closed access (OA after 2yrs) in Vireo ETD system","Limited"]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["Diverse functions of LanC-like proteins in mammalian cells"]}]}],"canonical_facts":{"dc:contributor":["van der Donk, Wilfred A.","Nair, Satish K.","Procko, Erik","Chen, Jie"],"dc:creator":["Lai, Kuan-Yu Nick"],"dc:date":["2020-08-27T00:46:46Z","2022-08-27T00:51:40Z","2020-01-15","2020-05"],"dc:description":["Bacterial LanC proteins have been extensively studied and shown to be responsible for installing thioether crosslinks in precursors of lanthipeptides. These modifications allow lanthipeptides to possess different biological activities such as antimicrobial activity. LanC-like proteins have been identified in various eukaryotic cells, but their function is not known. Intriguingly, the structure of the bi-functional enzyme CylM was solved and the dehydratase domain of LanM unexpectedly showed structural homology with mammalian kinases such as the mammalian target of rapamycin (mTOR). This finding has led us to look for potential interaction partners for LanCL proteins. In Chapter 2, I demonstrate that LanCL proteins physically interact with many cellular kinases in mammalian cells by using pulldown assays. Since LanCL proteins have been shown to bind glutathione (GSH), I hypothesized that LanCL proteins might act as post-translational modification enzymes to modify proteins/peptides. In this study, dehydroamino acids containing peptides that mimic the activation loop of Erk and Akt protein kinases were synthesized. LanCL proteins were shown to add GSH to these dehydroamino acids containing peptides. The same C-glutathionylation was also observed by using dehydroamino acid containing proteins as substrates. These data show that LanCL proteins have flexible capabilities to catalyze C-glutathionylation on different substrates. GC-MS analysis showed that the C-glutathionylation catalyzed by LanCL2 involves formation of DL-(methyl)lanthionine linkages. In order to probe the biological function of C-glutathionylation in mammalian cells, affinity purification mass spectrometry-based (AP-MS) proteomic analysis was performed which is presented in Chapter 3. Based on the bioinformatic analysis of the proteomic data, it seems LanCL2 participates in different metabolic pathways as well as protein degradation pathways. I therefore hypothesized that C-glutathionylation might act as a beacon for protein degradation; however, my preliminary data do not support a model that C-glutathionylation is a tag for protein degradation in mammalian cells. Instead, LanCL proteins may function to remove detrimental electrophilic sites from the proteome. In addition to acting as an enzyme in mammalian cells, we showed that LanCL2 might also act as a positive regulator for PPAR activity in Chapter 4. LanCL2 knockdown (KD) in preadipocytes led to disruption of their differentiation capability and pulldown assays showed that LanCL2 physically interacts with PPAR in HEK293 and 3T3-L1 cells. An in vitro binding study further showed that LanCL2 directly interacts with PPAR. Finally, luciferase reporter assays showed that LanCL2 is important for PPAR transactivation activity. Taken together, my thesis research suggests different roles of LanCL proteins in mammalian cells.","Submission published under a 24 month embargo labeled 'Closed Access', the embargo will last until 2022-05-01","The student, Kuan-Yu Lai, accepted the attached license on 2020-01-02 at 03:13.","The student, Kuan-Yu Lai, submitted this Dissertation for approval on 2020-01-02 at 03:20.","This Dissertation was approved for publication on 2020-01-15 at 09:10.","DSpace SAF Submission Ingestion Package generated from Vireo submission #14839 on 2020-08-25 at 17:38:16","Made available in DSpace on 2020-08-27T00:46:46Z (GMT). No. of bitstreams: 2 LAI-DISSERTATION-2020.pdf: 30449286 bytes, checksum: ad434a858aa9373a2ffc519987ba26b2 (MD5) LICENSE.txt: 4208 bytes, checksum: 9430999de29cd23c31dab22eac972954 (MD5) Previous issue date: 2020-01-15","Embargo set by: Seth Robbins for item 115827 Lift date: 2022-08-27T00:46:59Z Reason: Author requested closed access (OA after 2yrs) in Vireo ETD system","Embargo set by: Seth Robbins for item 115827 Lift date: 2022-08-27T00:50:22Z Reason: Author requested closed access (OA after 2yrs) in Vireo ETD system","Embargo set by: Seth Robbins for item 115827 Lift date: 2022-08-27T00:51:40Z Reason: Author requested closed access (OA after 2yrs) in Vireo ETD system","Author requested closed access (OA after 2yrs) in Vireo ETD system","Limited"],"dc:format":["application/pdf"],"dc:identifier":["http://hdl.handle.net/2142/108214"],"dc:language":["en"],"dc:rights":["Copyright 2019 Kuan-Yu Nick Lai"],"dc:subject":["LanCL, Enzyme, Glutathionylation"],"dc:title":["Diverse functions of LanC-like proteins in mammalian cells"],"dc:type":["text","Thesis"],"thesis:degree_discipline":["Biochemistry"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Ph.D."],"thesis:institution_name":["University of Illinois at Urbana-Champaign"]},"updated_at":"2026-07-22T22:24:48Z"}